H3K27me3 conditions chemotolerance in triple-negative breast cancer-Reference-Cited by-同舟云学术

H3K27me3 conditions chemotolerance in triple-negative breast cancer

Published:2022-04 Issue:4 Volume:54 Page:459-468
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Marsolier Justine^ORCID,Prompsy Pacôme,Durand Adeline^ORCID,Lyne Anne-Marie,Landragin Camille,Trouchet Amandine,Bento Sabrina Tenreira,Eisele Almut,Foulon Sophie,Baudre Léa,Grosselin Kevin,Bohec Mylène,Baulande Sylvain^ORCID,Dahmani Ahmed,Sourd Laura,Letouzé Eric^ORCID,Salomon Anne-Vincent^ORCID,Marangoni Elisabetta^ORCID,Perié Leïla^ORCID,Vallot Céline^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

https://www.nature.com/articles/s41588-022-01047-6.pdf

Reference50 articles.

1. Vallette, F. M. et al. Dormant, quiescent, tolerant and persister cells: four synonyms for the same target in cancer. Biochem. Pharmacol. 162, 169–176 (2019).

2. Shen, S., Vagner, S. & Robert, C. Persistent cancer cells: the deadly survivors. Cell 183, 860–874 (2020).

3. Ramirez, M. et al. Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells. Nat. Commun. 7, 10690 (2016).

4. Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431–435 (2017).

5. Cortazar, P. et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384, 164–172 (2014).

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

2. Hypertranscription: the invisible hand in stem cell biology;Trends in Genetics;2024-09

3. Branched-chain amino acid transaminase 1 confers EGFR-TKI resistance through epigenetic glycolytic activation;Signal Transduction and Targeted Therapy;2024-08-15

4. Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers;Genome Biology;2024-07-18

5. Cellular adaptation to cancer therapy along a resistance continuum;Nature;2024-07-10